Alector, Inc. Common Stock (ALEC)

NASDAQ: ALEC • USD
2.41 USD
-0.12 (-4.74%)
AT CLOSE (11:59 AM EDT)
2.41
+0.00 (+0.00%)
POST MARKET (AS OF 04:15 PM EDT)
🟢Market: OPEN
Open?$2.45
High?$2.52
Low?$2.13
Prev. Close?$2.53
Volume?1.3M
Avg. Volume?876.9K
VWAP?$2.28
Rel. Volume?1.50x
Bid / Ask
Bid?$2.38 × 100
Ask?$2.43 × 100
Spread?$0.05
Midpoint?$2.41
Valuation & Ratios
Market Cap?279.2M
Shares Out?110.4M
Float?88.3M
Float %?80.9%
P/E Ratio?N/A
P/B Ratio?9.11
EPS?-$1.30
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.83Strong
Quick Ratio?3.83Strong
Cash Ratio?0.95Adequate
Debt/Equity?0.32Low
ValuationRICHLY VALUED
Score
50/100
P/E?
N/A▾
P/B?
9.11HIGH▾
P/S?
13.27HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
-1.5CHEAP▾
EV/Sales?
10.60HIGH▾
Returns & Efficiency
ROE?
-466.3%WEAK▾
ROA?
-48.7%WEAK▾
Cash Flow & Enterprise
FCF?$-184072000
Enterprise Value?$223.1M
Related Companies
Loading...
News
Profile
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
Employees
103
Market Cap
279.2M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.alector.com
Listed
2019-02-07
Address
131 OYSTER POINT BLVD., SUITE 600
SOUTH SAN FRANCISCO, CA 94080
Phone: 415-231-5660
MarketsMoversWatchlist